- Home
- LXU vs KROS Comparison
LXU vs KROS Comparison
Compare LXU & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXU
- KROS
- Stock Information
- Founded
- LXU 1968
- KROS 2015
- Country
- LXU United States
- KROS United States
- Employees
- LXU N/A
- KROS N/A
- Industry
- LXU Major Chemicals
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- LXU Industrials
- KROS Health Care
- Exchange
- LXU Nasdaq
- KROS Nasdaq
- Market Cap
- LXU 494.2M
- KROS 465.2M
- IPO Year
- LXU 1969
- KROS 2020
- Fundamental
- Price
- LXU $6.57
- KROS $10.04
- Analyst Decision
- LXU Strong Buy
- KROS Buy
- Analyst Count
- LXU 4
- KROS 12
- Target Price
- LXU $10.75
- KROS $27.86
- AVG Volume (30 Days)
- LXU 355.9K
- KROS 708.7K
- Earning Date
- LXU 04-28-2025
- KROS 05-07-2025
- Dividend Yield
- LXU N/A
- KROS N/A
- EPS Growth
- LXU N/A
- KROS N/A
- EPS
- LXU N/A
- KROS N/A
- Revenue
- LXU $522,400,000.00
- KROS $3,550,000.00
- Revenue This Year
- LXU $7.34
- KROS $65.83
- Revenue Next Year
- LXU $5.76
- KROS $1.36
- P/E Ratio
- LXU N/A
- KROS N/A
- Revenue Growth
- LXU N/A
- KROS 2250.99
- 52 Week Low
- LXU $6.37
- KROS $9.41
- 52 Week High
- LXU $10.40
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- LXU 35.17
- KROS 35.08
- Support Level
- LXU $6.73
- KROS $11.18
- Resistance Level
- LXU $6.66
- KROS $11.63
- Average True Range (ATR)
- LXU 0.23
- KROS 0.42
- MACD
- LXU -0.02
- KROS -0.09
- Stochastic Oscillator
- LXU 19.31
- KROS 26.69
About LXU LSB Industries Inc.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.